Protalix BioTherapeutics ... (PLX)

AMEX: PLX · Real-Time Price · USD

3.00

0.00 (0.00%)

At close: May 02, 2025, 3:59 PM

3.00

-0.17%

After-hours: May 02, 2025, 04:05 PM EDT

Protalix BioTherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	2.93M	8.31M	-14.93M	-27.58M	-6.52M	-18.28M	-26.46M	-85.28M	-29.18M
Depreciation & Amortization	1.3M	1.19M	1.09M	1.12M	1.3M	1.62M	1.67M	1.92M	1.98M
Stock-Based Compensation	3.25M	3.45M	2.08M	2.38M	3.13M	835K	514K	337K	988K
Other Working Capital	-4K	-13.16M	-7.17M	13.23M	-26.2M	-9.58M	17.88M	26.76M	-411K
Other Non-Cash Items	138K	-638K	-1.23M	3.09M	3.64M	3.37M	3.07M	4.57M	581K
Deferred Income Tax	236K	-3.09M	n/a	813K	-522K	-68K	-64K	39.35M	-7.59M
Change in Working Capital	811K	-10.54M	-12.02M	9.9M	-27.13M	-6.83M	13.53M	29.1M	1.12M
Operating Cash Flow	8.67M	-1.32M	-25M	-10.29M	-26.11M	-19.36M	-7.74M	-9.99M	-32.1M
Capital Expenditures	-1.28M	-1.15M	-628K	-1.46M	-655K	-627K	-686K	-971K	-849K
Cash Acquisitions	n/a	n/a	n/a	53K	n/a	n/a	n/a	3K	20K
Purchase of Investments	n/a	n/a	-16M	-37.84M	-20M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	11M	57.84M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	5.5M	-15.56M	593K	327K	703K	-256K	95K	-148K	-118K
Investing Cash Flow	4.22M	-16.71M	-5.04M	18.92M	-19.95M	-883K	-591K	-1.12M	-967K
Debt Repayment	n/a	n/a	n/a	-34.12M	-215K	n/a	-4.75M	-1.42M	19.68M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-20.42M	712K	2K	46.2M	472K	n/a	n/a	n/a	14K
Financial Cash Flow	-16.79M	24.67M	8.24M	12.08M	46.47M	n/a	-4.75M	-1.42M	19.7M
Net Cash Flow	-3.87M	6.52M	-21.87M	20.72M	473K	-20.02M	-13.36M	-12.12M	-13.09M
Free Cash Flow	7.39M	-2.47M	-25.63M	-11.74M	-26.76M	-19.98M	-8.43M	-10.96M	-32.95M